CliffBio
small molecule

VERDESO

DESONIDE

Loss of exclusivityAugust 2027latest FDA-listed patent expiry
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameVERDESO
Active ingredientDESONIDE
Strength0.05%
Dosage formAEROSOL, FOAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalSeptember 2006
Marketing statusDISCN

Listed patents

PatentExpiresType
8460641August 2027product

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

VERDESO patent cliff — loss of exclusivity August 2027 | CliffBio